COMPANY

Lupin Pharmaceuticals Inc.

Lupin Pharmaceuticals Inc.: US labeler, recalling firm for Ganirelix, Glucagon, Liraglutide, as stated by public registers.

Also written as: Lupin Pharmaceuticals, Inc..

US LABELER

Lists a finished product with FDA (NDC directory); can be a maker, repackager or distributor.

Ganirelix	Ganirelix Acetate, ANDA Regulator openFDA
Glucagon	GLUCAGON, ANDA Regulator openFDA
Liraglutide	Liraglutide, ANDA Regulator openFDA

RECALLING FIRM

Recalled a product naming the peptide (FDA enforcement report).

Ganirelix	Class II recall, Ongoing, 2025-12-17 Regulator openFDA
Glucagon	Class II recall, Ongoing, 2026-07-08 Regulator openFDA
Liraglutide	Class II recall, Ongoing, 2026-05-27 Regulator openFDA

What a register states, not an endorsement or an accusation by this site. All companies.

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.